![Carrie Bourdow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carrie Bourdow
Amministratore Delegato presso
TREVENA, INC.
Profilo
Carrie L.
Bourdow is currently the Chairman & Chief Executive Officer at Trevena, Inc. She previously served as an Independent Director at Sesen Bio, Inc. from 2020 to 2023 and at Nabriva Therapeutics Plc from 2017 to 2023.
Prior to that, she was the Vice President-Marketing at Cubist Pharmaceuticals LLC from 2013 to 2015.
Ms. Bourdow holds an undergraduate degree from Hendrix College and an MBA from Southern Illinois University.
Posizioni attive di Carrie Bourdow
| Società | Posizione | Inizio |
|---|---|---|
| TREVENA, INC. | Amministratore Delegato | 01/10/2018 |
Precedenti posizioni note di Carrie Bourdow
| Società | Posizione | Fine |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Direttore/Membro del Consiglio | 30/07/2023 |
| CARISMA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 07/03/2023 |
| CUBIST PHARMACEUTICALS INC | Vendite & Marketing | 01/05/2015 |
Formazione di Carrie Bourdow
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
56
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Hendrix College
 Hendrix College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern Illinois University
 Southern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
